Mersana Therapeutics Free Cash Flow (Quarterly) Insights

Mersana Therapeutics Inc (MRSN)

3.37 0.00 (0.00%) USD | NASDAQ | May 02, 16:00

3.37 0.00 (0.00%) After-Hours: 20:00

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	-32.35M
September 30, 2023	-46.55M
June 30, 2023	-62.23M
March 31, 2023	-29.92M
December 31, 2022	-52.01M
September 30, 2022	54.17M
June 30, 2022	-45.43M
March 31, 2022	-8.284M
December 31, 2021	-42.56M
September 30, 2021	-36.14M
June 30, 2021	-34.80M
March 31, 2021	-27.14M
December 31, 2020	-17.51M
September 30, 2020	-20.39M
June 30, 2020	-15.96M
March 31, 2020	-21.31M

Date	Value
December 31, 2019	-12.58M
September 30, 2019	-16.31M
June 30, 2019	-14.40M
March 31, 2019	-25.06M
December 31, 2018	-16.18M
September 30, 2018	-10.75M
June 30, 2018	-12.00M
March 31, 2018	-17.66M
December 31, 2017	-11.71M
September 30, 2017	-11.19M
June 30, 2017	-9.546M
March 31, 2017	-11.38M
December 31, 2016	13.43M
September 30, 2016	-4.836M
June 30, 2016	-9.766M
March 31, 2016	31.68M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-62.23M

Minimum

Jun 2023

54.17M

Maximum

Sep 2022

-25.35M

Average

-27.14M

Median

Mar 2021

Free Cash Flow (Quarterly) Benchmarks